title: Familial pseudohyperkalaemia: inhibition of erythrocyte K+ efflux at 4 degrees C by quinine.
abstract: 1. Mechanisms responsible for increased erythrocyte K+ efflux in vitro have been investigated in a patient with familial pseudohyperkalaemia. Mean net K+ efflux (4 degrees C) was 108 nmol h-1 10(-9) erythrocytes, seven times greater than the mean for controls (15.2 nmol h-1 10(-9) erythrocytes). Net K+ efflux was not increased at 22 degrees C or 37 degrees C and losses at 4 degrees C were reversed by subsequent incubation at 37 degrees C. 2. Erythrocyte glucose consumption (4 degrees C) was 14 nmol h-1 10(-9) erythrocytes, similar to the mean for controls of 16.8 nmol h-1 10(-9) erythrocytes. This suggests that the increased net K+ efflux (4 degrees C) was not associated with abnormal energy consumption and was therefore unlikely to be due to an abnormality of the Na+, K+-pump. 3. Incubation of erythrocyte suspensions with ouabain (0.1 mmol/1) or frusemide (1 mmol/1) at 4 degrees C or 37 degrees C resulted in no differences in K+ efflux between patient and controls. Incubation with quinine (2 mmol/1), an inhibitor of the erythrocyte Ca2+-dependent K+ channel, reduced net K+ efflux at 4 degrees C, but the effect persisted in Ca2+-depleted erythrocytes, implying that quinine was acting in a non-specific fashion. 4. Chemical pathologists and clinicians must be aware of this condition if inappropriate treatment of pseudohyperkalaemia is to be avoided.
authors: Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff, U.K.
authors: D R
authors: DR
authors: James
authors: D
authors: D
authors: Stansbie
mesh_terms: D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism; D005665:Furosemide / Q000494:pharmacology; D006801:Humans; D006947:Hyperkalemia / Q000097:blood / Q000235:genetics*; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium / Q000037:antagonists & inhibitors* / Q000097:blood; D011803:Quinine / Q000494:pharmacology*; D012964:Sodium / Q000097:blood
chemical_list: D010042:Ouabain; D005665:Furosemide; D012964:Sodium; D011803:Quinine; D011188:Potassium